Visit CURE at http://curenet.org and CURE BioScience Explorations at http://bioscienceexplorations.org

   

Wednesday, January 25, 2012
4:00 pm - 6:00 pm

Anlyan Center, Yale University
300 Cedar Street, New Haven

Please RSVP to biohaven@yale.edu

 

Thetis Pharmaceuticals LLC

Panel discussion followed by networking, refreshments & wine bar

Thetis is a drug development company that is advancing TP101, a novel, first-line therapy for type 2 diabetes. TP101 is a new molecular entity that chemically combines metformin, the standard of care in type 2 diabetes, with the principal component from omega-3 polyunsaturated fatty acids. TP101 uniquely targets both glycemic and lipid control in diabetes patients and has the potential as a 2nd generation metformin with an improved therapeutic profile and better efficacy, as well as strong intellectual property protection. The company expects to begin clinical studies with TP101 in 2012, an exceptionally rapid timeline made possible by certain regulatory efficiencies associated with the known safety and efficacy records of its active pharmacologic agents.

Website: thetispharma.com

Speakers

Frank Sciavolino, PhD, Co-Founder, President, and Chief Scientific Officer
Gary Mathias, Co-Founder and Chief Financial Officer

The BioHaven Entrepreneurship Series features presentations designed to showcase regionally developed life science technologies that have progressed along the path to commercialization.  Speakers at the BioHaven events represent both the scientific and business side of the enterprises.

The programs focus on key success factors of each company, scientific or technological advantage, business model, and lessons learned in starting and developing the business. The series also provides social networking opportunities for scientists, researchers, and businessmen.

Wednesday, January 25, 2012
3:30 pm Registration Open
4:00 pm Program
5:00 pm Networking, Refreshments & Wine Bar

Location
Anlyan Center
300 Cedar Street, New Haven

Directions & Parking
http://info.med.yale.edu/maps/cab.html

RSVP
Registration is free, but please RSVP in advance. E-mail to biohaven@yale.edu or call the Yale OCR main number: 203-785-6209.

Next Scheduled BioHaven Event
February 28, 4:00 pm
Personalized Medicine: Is the Wait Over?
Anlyan Center
300 Cedar Street

Lead sponsors: Wiggin and Dana and PricewaterhouseCoopers

Also sponsored by Elm Street Ventures and the New Haven Economic Development Corporation.


Presented by CURE and the Yale Office of Cooperative Research.


Additional support from the Yale Entrepreneurial Institute and the Yale Healthcare & Life Sciences Club.

 

Quick Cut & Paste for Your Calendar
CURE/Yale BioHaven presents
Thetis Pharmaceuticals
Anlyan Center
300 Cedar Street
Wed Jan 25 2012 4:00 pm
 
 
Copyright 2011 © Connecticut United for Research Excellence. All rights reserved. Visit CURE at http://curenet.org and CURE BioScience Explorations at http://bioscienceexplorations.org
Click here for Archive of back issues.
Newsletter developed and edited by HarveyMalis Communications LLC, Guilford, Conn.

Managing Your Subscriptions
Click on the "Manage your subscription" link below and then on "Edit Your Profile." To subscribe to a publication, type a "y" in the box to the right of the publication name. To unsubscribe, leave the box blank.